| P2093 | author name string | Stefan Schülke | |
| P2860 | cites work | Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease | Q47882204 |
| | Counter regulation of the high affinity IgE receptor, FcepsilonRI, on human airway dendritic cells by IL-4 and IL-10. | Q47963657 |
| | Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice | Q48013055 |
| | Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. | Q48016882 |
| | Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness | Q49168932 |
| | Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC | Q50045631 |
| | IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes | Q50335910 |
| | Regulatory dendritic cells program generation of interleukin-4-producing alternative memory CD4 T cells with suppressive activity. | Q51031477 |
| | T cell derived IL-10 is dispensable for tolerance induction in a murine model of allergic airway inflammation. | Q51709154 |
| | Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. | Q51971437 |
| | Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. | Q51982787 |
| | Effects of cyclosporine on human dendritic cell subsets. | Q51993098 |
| | Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. | Q52592976 |
| | Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. | Q52914622 |
| | A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy. | Q53088336 |
| | Seasonal changes in suppressive capacity of CD4+ CD25+ T cells from patients with hayfever are allergen-specific and may result in part from expansion of effector T cells among the CD25+ population. | Q53382422 |
| | The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10. | Q54435801 |
| | CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity | Q56904531 |
| | Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis | Q64378678 |
| | IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes | Q70466606 |
| | Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance | Q72230111 |
| | Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors | Q73201969 |
| | Elevated RANTES levels in plasma or skin and decreased plasma IL-10 levels in subsets of patients with severe atopic dermatitis | Q73347302 |
| | Effect of interleukin-10 on dendritic cell maturation and function | Q73396250 |
| | Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo | Q73407790 |
| | Induction of tolerance by IL-10-treated dendritic cells | Q73873437 |
| | Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen | Q74286698 |
| | Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells | Q74481827 |
| | Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? | Q74675085 |
| | Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4 | Q77178595 |
| | Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation | Q77353738 |
| | Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells | Q77785419 |
| | Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro | Q78066649 |
| | A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0/Th1 and IL-10-producing regulatory T cells | Q79912630 |
| | IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice | Q79922675 |
| | Suppression of allergic inflammation by allergen-DNA-modified dendritic cells depends on the induction of Foxp3+ Regulatory T cells | Q80506809 |
| | Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation | Q80754264 |
| | Role of regulatory dendritic cells in allergy and asthma | Q81247425 |
| | Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation | Q82391174 |
| | Dendritic cells lentivirally engineered to overexpress interleukin-10 inhibit contact hypersensitivity responses, despite their partial activation induced by transduction-associated physical stress | Q82825105 |
| | Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli | Q84038049 |
| | TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy | Q84255344 |
| | Innate and lymphocytic response of birch-allergic patients before and after sublingual immunotherapy | Q84521358 |
| | Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis | Q85917606 |
| | Different capacity of in vitro generated myeloid dendritic cells of newborns of healthy and allergic mothers to respond to probiotic strain E. coli O83:K24:H31 | Q88175831 |
| | Interleukin-10 and the interleukin-10 receptor | Q24290912 |
| | Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity | Q24302386 |
| | The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells | Q24304323 |
| | Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI | Q24312126 |
| | Identification and functional characterization of a second chain of the interleukin-10 receptor complex | Q24315000 |
| | HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j | Q24321583 |
| | Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. | Q25255561 |
| | Prevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC | Q27323956 |
| | The interleukin-1 family: 10 years of discovery | Q28243296 |
| | Interleukin-10 and related cytokines and receptors | Q28251518 |
| | Enhanced production of CCL18 by tolerogenic dendritic cells is associated with inhibition of allergic airway reactivity | Q28278071 |
| | An aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress the Th17 response in allergic rhinitis patients | Q28307542 |
| | Immunobiology of dendritic cells | Q29547465 |
| | The regulation of IL-10 production by immune cells | Q29615479 |
| | Tolerogenic dendritic cells | Q29618755 |
| | Taking dendritic cells into medicine | Q29619243 |
| | The dendritic cell system and its role in immunogenicity | Q29619870 |
| | Targeting Toll-like receptors on dendritic cells modifies the T(H)2 response to peanut allergens in vitro | Q33987620 |
| | Dendritic cell regulation of TH1-TH2 development | Q34023428 |
| | Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. | Q34060888 |
| | IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses | Q34330562 |
| | Dendritic cell and T cell responses in children with food allergy | Q34424827 |
| | The role of interleukin 10 in the regulation of allergic immune responses | Q34453932 |
| | Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression | Q34504988 |
| | Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival | Q34611787 |
| | Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy | Q34613611 |
| | B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function. | Q34788681 |
| | Helicobacter pylori colonization is inversely associated with childhood asthma | Q34791821 |
| | Dendritic cell populations in patients with self-reported food hypersensitivity | Q34999740 |
| | Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs | Q35140130 |
| | Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells. | Q44808179 |
| | Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 |
| | TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells | Q45256168 |
| | Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells | Q45878833 |
| | Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. | Q45949848 |
| | Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity | Q46061458 |
| | First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children | Q46182948 |
| | Effects of Helicobacter pylori, geohelminth infection and selected commensal bacteria on the risk of allergic disease and sensitization in 3-year-old Ethiopian children. | Q46488102 |
| | Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity | Q46675736 |
| | Targeting of Immune Cells by Dual TLR2/7 Ligands Suppresses Features of Allergic Th2 Immune Responses in Mice. | Q47159679 |
| | Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. | Q47256460 |
| | In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation | Q47794289 |
| | Critical role of mammalian target of rapamycin for IL-10 dendritic cell induction by a flagellin A conjugate in preventing allergic sensitization. | Q47832800 |
| | Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells | Q35142836 |
| | A specific role for TLR1 in protective T(H)17 immunity during mucosal infection | Q36131717 |
| | Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussi | Q36369855 |
| | Translating innate immunity into immunological memory: implications for vaccine development | Q36404657 |
| | Ins and outs of dendritic cells | Q36420211 |
| | Dendritic cells in a mature age. | Q36475977 |
| | New hepatitis B vaccine formulated with an improved adjuvant system | Q36780117 |
| | Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. | Q37133445 |
| | IL-10: the master regulator of immunity to infection | Q37143028 |
| | Interferons modulate Fc epsilon RI-dependent production of autoregulatory IL-10 by circulating human monocytoid dendritic cells | Q37171962 |
| | Interaction of regulatory T cells with antigen-presenting cells in health and disease | Q37273111 |
| | Role of interleukin 10 in specific immunotherapy | Q37387064 |
| | Tolerogenic dendritic cells derived from donors with natural rubber latex allergy modulate allergen-specific T-cell responses and IgE production | Q37505188 |
| | The multifunctional role of mTOR in innate immunity: implications for transplant immunity. | Q37605193 |
| | Chlamydia infection induces ICOS ligand-expressing and IL-10-producing dendritic cells that can inhibit airway inflammation and mucus overproduction elicited by allergen challenge in BALB/c mice | Q37862486 |
| | Regulation of immune responses by mTOR. | Q37963950 |
| | Regulatory functions of B cells in allergic diseases | Q38233691 |
| | Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain | Q38351898 |
| | Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity. | Q38363375 |
| | The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma | Q38862916 |
| | Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction | Q40259087 |
| | Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation. | Q40300866 |
| | Diminished dendritic cell interleukin 10 production in atopic children | Q40504526 |
| | Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses. | Q40511372 |
| | CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation | Q40707024 |
| | Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. | Q40726379 |
| | Diminished IL-10 production in subjects with allergy after infection with influenza A virus | Q40810461 |
| | IL-10 control of dendritic cells in the skin. | Q40929447 |
| | Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. | Q40971390 |
| | Mechanisms of antigen uptake for presentation | Q41102979 |
| | MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS. | Q41156645 |
| | Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo. | Q41717896 |
| | Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity | Q41745934 |
| | Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells | Q41853652 |
| | IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes | Q42453935 |
| | Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells | Q42618400 |
| | A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses In Vitro | Q42713288 |
| | Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses | Q42943035 |
| | Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 |
| | Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites. | Q43163403 |
| | Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years | Q43452461 |
| | Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells | Q43701906 |
| | Dendritic cells from mycobacteria-infected mice inhibits established allergic airway inflammatory responses to ragweed via IL-10- and IL-12-secreting mechanisms | Q43731064 |
| | cAMP-elevating agents suppress dendritic cell function. | Q43819937 |
| | A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. | Q43944876 |
| | IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy | Q44429951 |
| | Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. | Q44467274 |
| | Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages | Q44701516 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | immune tolerance | Q1356761 |
| | hypersensitivity | Q5958765 |
| | allergen | Q186752 |
| | dendritic cell | Q506253 |
| | Th2 cells | Q67101694 |
| | interleukin-10 | Q24766641 |
| P304 | page(s) | 455 | |
| P577 | publication date | 2018-03-19 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses. | |
| P478 | volume | 9 | |